Efficacy and safety of tafluprost 0.0015% – retrospective analysis of real-world data from the Philippines

Código QR

Efficacy and safety of tafluprost 0.0015% – retrospective analysis of real-world data from the Philippines

Joseph Anthony Tumbocon,1,2 Anne Marie Macasaet11Eye Institute, St. Luke’s Medical Center, Quezon City, Philippines; 2Department of Ophthalmology, St. Luke’s College of Medicine, Quezon City, PhilippinesCorrespondence: Joseph Anthony TumboconEye Institute, St. Luke’s Me...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Tumbocon JA, Macasaet AM
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	Tafluprost 0.0015% Primary Open Angle Glaucoma IOP reduction Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/b7703b9e7bb74b49b9a834aadca9bcd1
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% in patients with open-angle glaucoma and ocular hypertension: results of an open-label observational study
por: Pillunat LE, et al.
Publicado: (2017)

The 24-hour intraocular pressure control by tafluprost/timolol fixed combination after switching from the concomitant use of tafluprost and timolol gel-forming solution, in patients with primary open-angle glaucoma
por: Nakamoto K, et al.
Publicado: (2018)

Effects of different sleeping positions on intraocular pressure in secondary open-angle glaucoma and glaucoma suspect patients
por: Sedgewick JH, et al.
Publicado: (2018)

Combined Gonioscopy-Assisted Transluminal Trabeculotomy (GATT) with Ab Interno Canaloplasty (ABiC) in Conjunction with Phacoemulsification: 12-Month Outcomes
por: Al Habash A, et al.
Publicado: (2020)

Efficacy and tolerability of preservative-free tafluprost 0.0015% in Korean patients with glaucoma
por: Hwang YH
Publicado: (2013)

Suppression of Diurnal (9AM–4PM) IOP Fluctuations with Minimally Invasive Glaucoma Surgery: An Analysis of Data from the Prospective, Multicenter, Single-Arm GEMINI Study
por: Pyfer MF, et al.
Publicado: (2021)

Ocular Surface Changes After Switching from Other Prostaglandins to Tafluprost and Preservative-Free Tafluprost in Glaucoma Patients
por: Ruangvaravate N, et al.
Publicado: (2020)

Overnight Safety Evaluation of a Multi-Pressure Dial in Eyes with Glaucoma: Prospective, Open-Label, Randomized Study
por: Ferguson TJ, et al.
Publicado: (2020)

The signs of ocular-surface disorders after switching from latanoprost to tafluprost/timolol fixed combination: a prospective study
por: Okumichi H, et al.
Publicado: (2017)

Benefits of switching from latanoprost to preservative-free tafluprost eye drops: a meta-analysis of two Phase IIIb clinical trials
por: Uusitalo H, et al.
Publicado: (2016)

Evaluating intraocular pressure-lowering solutions for the treatment of open-angle glaucoma: comparison between bimatoprost 0.03% and bimatoprost 0.01% – an observational switch study
por: Deshpande SS, et al.
Publicado: (2017)

Minimally Invasive Surgery in Mild-to-Moderate Glaucoma Patients in Italy: Is It Time to Change?
por: Costagliola C, et al.
Publicado: (2020)

Prospective, randomized study of one, two, or three trabecular bypass stents in open-angle glaucoma subjects on topical hypotensive medication
por: Katz LJ, et al.
Publicado: (2015)

Switching from concomitant therapy to tafluprost/timolol fixed combination
por: Inoue K, et al.
Publicado: (2018)

Investigation of intraocular pressure fluctuation as a risk factor of glaucoma progression
por: Matlach J, et al.
Publicado: (2018)

Comparison of Medical Comorbidity between Patients with Normal-Tension Glaucoma and Primary Open-Angle Glaucoma: A Population-Based Study in Taiwan
por: Wei-Yang Lu, et al.
Publicado: (2021)

Improved Efficacy of Topical Latanoprost 0.005% Demonstrated by Corneal Biomechanical Correcting Modified Goldmann Prism
por: Radcliffe N, et al.
Publicado: (2020)

The Effect of Brimonidine 0.1% on Disc Hemorrhage in Primary Open-Angle Glaucoma Patients
por: Nitta K, et al.
Publicado: (2020)

Comparison between the EX-PRESS P-50 implant and trabeculectomy in patients with open-angle glaucoma
por: Mendoza-Mendieta ME, et al.
Publicado: (2016)

Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension
por: Wang N, et al.
Publicado: (2020)

Relationship between visual field progression and baseline refraction in primary open-angle glaucoma
por: Naito T, et al.
Publicado: (2016)

8 hrs Safety Evaluation Of A Multi-Pressure Dial In Eyes With Glaucoma: Prospective, Open-Label, Randomized Study
por: Samuelson TW, et al.
Publicado: (2019)

Clinical evaluation of a trabecular microbypass stent with phacoemulsification in patients with open-angle glaucoma and cataract
por: Ferguson TJ, et al.
Publicado: (2016)

Comparison of ab externo trabeculotomy in primary open-angle glaucoma and uveitic glaucoma: long-term outcomes
por: William A, et al.
Publicado: (2016)

Outcomes of Combined iStent Trabecular Micro-Bypass and Cataract Surgery for the Treatment of Open-Angle Glaucoma in a Saudi Population
por: Al Habash A, et al.
Publicado: (2020)

Canaloplasty and Trabeculotomy Combined with Phacoemulsification in Open-Angle Glaucoma: Interim Results from the GEMINI Study
por: Gallardo MJ, et al.
Publicado: (2021)

Individualized Significance of 24-Hour Intraocular Pressure Curves for Therapeutic Decisions in Primary Chronic Open-Angle Glaucoma Patients
por: Lever M, et al.
Publicado: (2020)

Efficacy of two trabecular micro-bypass stents combined with topical travoprost in open-angle glaucoma not controlled on two preoperative medications: 3-year follow-up
por: Chang DF, et al.
Publicado: (2017)

Outcomes of combined trabecular micro-bypass and phacoemulsification in a predominantly Hispanic patient population
por: Gallardo MJ, et al.
Publicado: (2016)

360° ab-interno trabeculotomy in refractory primary open-angle glaucoma
por: Sarkisian SR, et al.
Publicado: (2019)

iStent Trabecular Microbypass Stent Implantation with Phacoemulsification in Patients with Open-Angle Glaucoma: 6-Year Outcomes
por: Ferguson TJ, et al.
Publicado: (2020)

Levels of circulating homocysteine, vitamin B6, vitamin B12, and folate in different types of open-angle glaucoma
por: Burak Turgut, et al.
Publicado: (2010)

Viscodilation of Schlemm’s canal for the reduction of IOP via an ab-interno approach
por: Gallardo MJ, et al.
Publicado: (2018)

Circumferential Viscodilation Ab Interno Combined with Phacoemulsification for Treatment of Open-Angle Glaucoma: 12-Month Outcomes
por: Tracer N, et al.
Publicado: (2020)

A One-Year Follow-Up of Two Ahmed Glaucoma Valve Models (S2 and FP7) for Refractory Glaucoma: A Prospective Randomized Trial
por: Elbaklish KH, et al.
Publicado: (2020)

Utility Of Three-Dimensional Heads-Up Surgery In Cataract And Minimally Invasive Glaucoma Surgeries
por: Ohno H
Publicado: (2019)

EX-PRESS DRAINAGE DEVICE IN PATIENTS WITH REFRACTORY AND PRIMARY OPEN-ANGLE GLAUCOMA
por: M. M. Bikbov, et al.
Publicado: (2016)

Treatment Success Across Different Levels of Preoperative Disease Burden: Stratified Two-Year Outcomes from the Pivotal Trial of iStent inject® Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract
por: Singh IP, et al.
Publicado: (2021)

No differences in central corneal thickness between open-angle and pseudoexfoliation glaucoma patients
por: Ayala M, et al.
Publicado: (2017)

Three-year outcomes of combined trabecular micro-bypass and phacoemulsification in a predominantly Hispanic population with primary open-angle glaucoma
por: Gallardo MJ, et al.
Publicado: (2019)